INS and type 2 diabetes mellitus: Studies have demonstrated that race, age, duration of T2D, weight, body mass index (BMI), glycosylated hemoglobin (HbA1c) level, fasting plasma glucose (FPG) level, fasting C-peptide level (FCP) concentration, preoperative insulin use, and hypertension may affect the outcomes of MS [15–23].